Abstract
The last decade has been a time of active and fruitful interest in the development of hepatobiliary radiopharmaceuticals. In order to compare potential radiopharmaceuticals, define their biological behavior, and obtain data that would indicate behavior under clinical conditions, a variety of animal species and even isolated hepatocytes have been used. This chapter reviews the use of these animal models with respect to the type of information to be gained, advantages and disadvantages of the species under study, and correlation of data from one species to another as well as to the ultimate species, man.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adolph, E. F. (1949). Quantitative relations in the physiological constitutions of mammals. Science 109:579–585.
Alpert, S., Mosher, M., and Shanske, A. (1969). Multiplicity of hepatic excretory mechanisms for organic anions. J. Gen. Physiol. 53:288–247.
Altman, P. L., and Dittmer, D. S. (1972a). Biology Data Book. Bethesda: Federation of American Societies for Experimental Biology, pp. 1703–1706.
Altman, P. L., and Dittmer, D. S. (1972b). Biology Data Book. Bethesda: Federation of American Societies for Experimental Biology, pp. 1841–1849.
Arias, I. M. (1972). Transfer of bilirubin from blood to bile. Sem. Hematol. 9:55–70.
Arias, I. M., Fleishner, G., Kirsch, R., Mishkin, S., and Gatmaitan, F. (1976). Glutathione: Metabolism and Function, Arias, I. M., Jakoby, W. B., eds. New York: Raven Press, pp. 175.
Arias, I. M., Gartner, L. M., Cohen, M., Ben-Ezzer, J., and Levi, A. J. (1969). Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Am. J. Med. 47:395–409.
Aziz, F. T. A., Hirom, P. C., Millburn, P., Smith, R. L., and Williams, R. T. (1971). The biliary excretion of anions of molecular weight 300–800 in the rat, guinea pig and rabbit. Biochem. J. 125:25–26P.
Baker, R. J., Bellen, J. C., and Ronai, P. M. (1975). Technetium 99mTc-pyridoxyli- deneglutamate: A new hepatobiliary radiopharmaceutical. 1. Experimental aspects. J. Nucl. Med. 16:720–727.
Benet, L. Z., and Galeazzi, R. L. (1979). Noncompartmental determination of the steady-state volume of distribution, J. Pharm. Sci. 68:1071–1074.
Benet, L. Z., and Ronfeld, R. A. (1969). Volume terms in pharmacokinetics, J. Pharm. Sci. 58:639–641.
Berry, M. N., and Friend, D. S.: (1969). High yield preparation of isolated rat liver parenchymal cells. J. Cell. Biol. 43:405–520.
Billing, B. H., Williams, R., and Richards, T. G. (1964). Defects in hepatic transport of bilirubin in congenital hyperbilirubinemia: An analysis of plasma bilirubin disappearance curves. Clin. Sci. 27:245–257.
Black, M., and Billing, B. H. (1969). Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease and Gilbert’s syndrome. N. Engl. J. Med. 280:1266–1271.
Boxenbaum, H. (1980). Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to enzodiazepines and phenytoin, J. Pharmacol. Biopharmacol. 8:165–176.
Chervu, L. R., Nunn, A. D., and Loberg, M. D. (1982). Radiopharmaceuticals for hepatobiliary imaging. Sem. Nucl. Med. 12:5–17.
Chervu, L. R., Robbins, E. B., Huq, S. S., and Blaufox, M. D. (1979). In vivo and in vitro studies of Tc-99m HIDA uptake. J. Nucl. Med. 20:655.
Chiotellis, E., and Varvarigou, A. (1980). 99mTc-labeled N-substituted carbamoyl iminodiacetates: Relationship between structure and biodistribution. Int. J. Nucl. Med. Biol. 7:1–7.
Cooper, B., Eakins, M. N., and Slater, T. F. (1976). The effect of various anesthetic techniques on the flow rate, constituents and enzyme composition of rat bile. Biochem. Pharmacol. 25:1711–1718.
Dhumeaux, D., Berthelot, P., and Javitt, N. B. (1974). Dibromosulfophthalein (DBSP) estimation of hepatic transport function in man. Eur. J. Clin. Invest. 4:181–185.
Dubin, I. N., and Johnson, F. B. (1954). Chronic idiopathic jaundice with unidentified pigment in liver cells. Medicine 33:155–197.
Fevery, J., Leroy, P., Van De Vijver, M., and Heirwegh, K. P. M. (1972). Enzymic transfer of glucose and xylose from uridine diphosphate glucose and uridine diphosphate xylose to bilirubin by untreated and digitonin-activated preparations from rat liver. Biochem. J. 129:619–633.
Fischer, E., Barth, A., Varga, F., and Klinger, W. (1979). Age dependence of hepatic transport in control and phenobarbital-pretreated rats. Life Sci. 24:557–562.
Fritzberg, A. R. (1981). The evaluation of hepatocyte function with radiotracers. In Studies of Cellular Function Using Radiotracers. M. W. Billinghurst, ed., Boca Raton, Fla.: CRC Press, pp. 73–92.
Fritzberg, A. R., Bloedow, D. C., Klingensmith, W. C., and Whitney, W. P. (1982a). Comparative study of 99mTc-hepatobiliary agents based on naphthalene and similar ring systems. Int. J. Nucl. Med. Biol. 9:1–11.
Fritzberg, A. R., and Klingensmith, W. C. (1982). Teaching editorial: Quest for the perfect hepatobiliary radiopharmaceutical. J. Nucl. Med. 23:543–546.
Fritzberg, A. R., Klingensmith III, W. C., Whitney, W. P., and Kuni, C. C. (1981). Chemical and biological studies of Tc-99mN, N’-bis(mercaptoacetamido)ethylenediamine: A potential replacement for 1–131 iodohippurate. J. Nucl. Med. 22:258–263.
Fritzberg, A. R., Kuni, C.C., Klingensmith, W. C., Stevens, J., and Whitney, W. P. (1982b). Synthesis and biological evaluation of Tc-99m N, N’-bis(mercaptoace- tyl)-2,3-diaminopropanoate: A potential replacement for [-131]o-iodohippurate. J. Nucl. Med. 23:592–598.
Fritzberg, A. R., and Reichen, J. (1983). Direct measurement of extraction efficiencies and mean transit times of hepatobiliary agents in the perfused rat liver. J. Nucl. Med., 24:126.
Fritzberg, A. R., Whitney, W. P., and Klingensmith III, W. C. (1979). Hepatobiliary transport mechanism of Tc-99m diethyl-IDA. In Radiopharmaceuticals II, Sodd, V. J., Allen, D. R., Hoogland, D. R., Ice, R. I., eds. New York: Society of Nuclear Medicine, pp. 566–586.
Frizzell, R. A., and Heintze, K. (1980). Transport functions of the gallbladder. In Liver and Biliary Tract Physiology I, Int. Rev. Physiol., Vol. 21, Javitt, N. B., ed. Baltimore: University Park Press, pp. 221–247.
Gelius, L., Skretting, A., and Aas, M. (1981). A mathematical model for the liver uptake and excretion of 99mTc-diethyl-IDA. Eur. J. Nucl. Med. 6:139–142.
Gibaldi, M., and McNamara, P. J. (1978). Apparent volumes of distribution and drug binding to plasma proteins and tissues. Eur. J. Clin. Pharmacol. 13:373–378.
Gibaldi, M., and Perrier, D. (1975a). Pharmacokinetics. New York: Marcel Dekker, pp. 175–187.
Gibaldi, M., and Perrier, D. (1975b). Pharmacokinetics. New York: Marcel Dekker, p. 315.
Gillette, J. R. (1971). Factors affecting drug metabolism. Ann. N.Y. Acad. Sci. 179:43–66.
Goresky, C. A. (1980). Uptake in the liver. The nature of the process. In Liver and Biliary Tract Physiology I, Int. Rev. Physiol., Vol. 21, Javitt, N. B., ed. Baltimore: University Park Press, pp. 65–101.
Goresky, C. A., and Kleiger, S. W. (1969). The relation between bile flow and transport maximum for bilirubin in the dog. Gasteroenterology 56:398.
Habig, W., Pabst, M., Fleishner, G., Gatmaitan, F., Arias, I. M., and Jakoby, W. (1974). The identity of glutathione transferase B with ligandin, a major binding protein of the liver. Proc. Natl. Acad. Sci. USA 71:3879–3882.
Hanks, J. B., Meyers, W. C., Willman, C. L., Hill, R. C., and Jones, R. S. (1980). The effect of cell-free and erythrocyte-containing perfusion in rat livers. J. Surg. Res. 24:149–160.
Harvey, E., Loberg, M., Ryan, J., Sikorski, S., Faith, W., and Cooper, M. (1979). Hepatic clearance mechanism of Tc-99m-HIDA and its effect on quantitation of hepatobiliary function. J. Nucl. Med. 20:310–313.
Henrikson, J. H., and Winkler, K. (1978). Pharmacokinetics of 99mTc-diethyl-IDA in man. In Proceedings of Symposium on Hepatobiliary Scintigraphy by Means of IDA Derivatives. Biersack, H. J., Maxsted, J., eds. Darmstadt: G.I.T. Verlag E. Giebeler, pp. 55–70.
Herz, R., Cueni, B., Bircher, J., and Paumgartner, G. (1973). The excretory capacity of the isolated perfused rat liver. Naunyn Schmiedebergs Arch. Pharmacol. 277:297–304.
Hirom, P. C., Millburn, P., and Smith, R. L. (1976). Bile and urine as complementary pathways for the excretion of foreign compounds. Xenobiotica 6:55–64.
Iga, T., and Klaassen, C. D. (1982). Hepatic extraction of bile acids in rats. Biochem. Pharmacol. 31:205–209.
Jansholt, A.-L., Vera, D. R., Krohn, K. A., and Stadalnik, R. C. (1979). In vivo kinetics of hepatobiliary agents in jaundiced animals. In Radiopharmaceuticals II, Sodd, V. J., Allen, D. R., Hoogland, D. R., Ice, R. D., eds., New York: Society of Nuclear Medicine, pp. 555–564.
Jones, A. B., Davison, A., LaTegola, M. R., Brodack, J. W., Orvig, C., Sohn, M., Toothaker, A. K., Lock, C. J. L., Franklin, K. J., Costello, C. E., Carr, S. A., Biemann, K., and Kaplan, M. L. (1982). Chemical and in vivo studies of the anion oxo N. N.’-ethylenebis(2-mercaptoacetimido)]technetate(V). J. Nucl. Med. 23:801–809.
Kato-Azuma, M. (1981). Identification of a mixed ligand complex of technetium-99m: A chromatographic approach to the chemical structure of carrier free tech- netium-99m (Sn) pyridoxylideneaminate. Int. J. Appl. Rad. Isot. 32:187–189.
Kato-Azuma, M. (1982). Tc-99m(Sn)-N-pyridoxylaminates: A new series of hepatobiliary imaging agents. J. Nucl. Med. 23:517–524.
Kato, M., and Hazue, M. (1978). Tc-99m-(Sn)pyridoxylidene aminates: Preparation and biological evaluation. J. Nucl. Med. 19:397–406.
Klaassen, C. D. (1975). Biliary excretion of xenobiotics. CRC Crit. Rev. Toxicol. 4:1–30.
Klaassen, C. D., and Plaa, G. L. (1967). Species variation in metabolism, storage, and excretion of sulfobromophthalein. Am. J. Physiol. 213:1322–1326.
Klingensmith, W. C., Fritzberg, A. R., Spitzer, V. M., Kuni, C. C., and Shanahan, W. S. M. (1981). Clinical comparison of diisopropyl-IDA Tc-99m and diethyl-IDA Tc-99m for evaluation of the hepatobiliary system. Radiology 140:791–795.
Klingensmith, W., Fritzberg, A., Spitzer, V., Kuni, C., Williamson, M., Gerhold, J., Nunn, A., Loberg, M., and Beisicki, T. (1982). Clinical evaluation of Tc-99m- mebrofenin and comparison with Tc-disofenin for radionuclide hepatobiliary imaging. Proceedings of World Fed. Nucl. Med. Biol. Mtng., Paris, pp. 1596–1598.
Klingensmith, W. C., Gerhold, J. P., Fritzberg, A. R., Spitzer, V. M., Kuni, C. C., Singer, C. J., and Weil, R. (1982). Clinical comparison of Tc-99m-N. N’ -bis(mer- captoacetamido)ethylenediamine and I-131-hippuran for evaluation of renal tubular function. J. Nucl. Med. 23:377–380.
Klingensmith, W. C., Whitney, W. P., Spitzer, V. M., Klintmalm, G. B. G., Koep, L. M., and Kuni, C. C. (1981). Effect of complete biliary-tract obstruction on serial hepatobiliary imaging in an experimental model. J. Nucl. Med. 22:866–868.
Kurz, H., Trunk, H., and Weitz, B. (1977). Evaluation of methods to determine protein-binding of drugs. Arzneim-Forsch 27:1373–1380.
Levi, A. T., Gatmaitan, Z., and Arias, I. M. (1969). Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J. Clin. Invest. 48:2156–2160.
Levy, M. L., Palazzi, H. M., Nardi, G. L., and Bunker, J. P. (1961). Hepatic blood flow variations during surgical anesthesia in man measured by radioactive colloid. Surg. Gyn. Obstet. 112:289–294.
Litwack, G., Ketterer, B., and Arias, I. M. (1971). Ligandin, An abundant liver protein which binds steroids, bilirubin, carcinogens, and a number of exogenous anions. Nature (Lond.) 234:466–467.
Loberg, M. D., Cooper, M., Harvey, E., Callery, P., and Faith, W. (1976). Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid. J. Nucl. Med. 17:633–638.
Loberg, M. D., Nunn, A. D., and Porter, D. W. (1981). Development of hepatobiliary imaging agents. In Nuclear Medicine Annual 1981, Freeman, L. M., and Weissmann, H. S., eds., New York: Raven Press, pp. 1–33.
Loberg, M. D., and Porter, D. W. (1979). Review and current status of hepatobiliary agents. In Radiopharmaceuticals II., Eds., Sodd, V. J., Allen, D. R., Hoogland, D. R., and Ice, R. D. New York: Society of Nuclear Medicine, pp. 555–564.
Mia, A. S., Gronwald, R. R., and Cornelius, C. E. (1920). Bilirubin-14C turnover studies in normal and mutant Southdown sheep with congenital hyperbilirubinemia. Proc. Soc. Exp. Biol. Med. 133:955–959.
Miller, L. L. (1973). Technique of isolated rat liver perfusion. In Isolated Liver Perfusion and Its Applications. Bartosek, I., Guaitani, A., Miller, L. L., eds. New York: Raven Press, pp. 11–52.
McLean, E. K., McLean, A. E. M., and Sutton, P. M. (1969). Instant cirrhosis: An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone. Br. J. Exp. Pathol. 50:502–506.
Nunn, A. D., Loberg, M. D., Conley, R. A., and Schram, E. (1981). The development of a new cholescintigraphic agent, Tc-SQ 26,962, using a structure-distribution relationship approach. J. Nucl. Med. 22:P51.
O’Maille, E. R. L., Richards, T. G., and Short, A. H. (1966). Factors determining the maximal rate of organic anion secretion by the liver and further evidence on the hepatic site of action of the hormone secretin. J. Physiol. (Lond) 186:424–438.
Paterson, J. Y. F., and Harrisonn, F. A. (1972). The splanchnic and hepatic uptake of Cortisol in conscious and anesthetized sheep. J. Endocrinol. 55:335–350.
Pries, J. M., Staples, A. B., and Hansen, R. F. (1981). The effect of hepatic blood flow on taurocholate extraction by the isolated perfused rat liver. J. Lab. Clin. Med. 97:412–417.
Raymond, G. D. (1966). Gastroenterology 50:862–863.
Reichen, J., and Paumgartner, G. (1976). Uptake of bile acids by perfused rat liver. Am. J. Physiol. 231:734–742.
Reichen, J., and Paumgartner, G. (1980). Excretory function of the liver. In Liver and Biliary Tract Physiology I, Int. Rev. Physiol., Vol. 21, Javitt, N. B., ed., Baltimore: University Park Press, pp. 103–150.
Roberts, R. J., Klaassen, C. D., and Plaa, G. L. (1967). Maximum biliary excretion of bilirubin and sulfobromophthalein during anesthesia-induced alteration of rectal temperature. Proc. Soc. Exp. Biol. Med. 125:313–316.
Roberts, R. J., and Plaa, G. L. (1967). Alterations of the plasma disappearance and biliary excretion patterns of exogenously administered bilirubin by a-napthyli-sothiocyanate. J. Pharmacol. Exp. Ther. 155:330–336.
Roberts, R. J., and Plaa, G. L. (1967). Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem. Pharmacol. 16:827–835.
Roberts, R. J., Shriver, S. L., and Plaa, G. L. (1968). Effect of norethandrolone on the biliary excretion of bilirubin in the mouse and rat. Biochem. Pharmacol. 17:1261–1268.
Rowland, M., and Tucker, G. (1980). Scientific commentary. Symbols in pharmacokinetics. J. Pharmacokin. Biopharm. 8:497–507.
Ryan, J., Cooper, M., Loberg, M., Harvey, E., Sikorski, S.: Technetium-99m-labeled N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid (Tc-99m HID A): A new radiopharmaceutical for hepatobiliary imaging studies. J. Nucl. Med. 18:995–1002.
Schanker, L. S. (1968). Secretion of organic compounds into bile. In Handbook of Physiology, Vol. 5, Code, C. F., and Heidel, W., eds. Washington, D.C.: American Physiology Society, pp. 2433–2450.
Schwenk, M. (1980). Transport systems of isolated hepatocytes. Studies on the transport of biliary compounds. Arch. Toxicol. 44:113–126.
Smith, R. L. (1973). Species variations in biliary excretion. In The Excretory Function of Bile. London: Chapman and Hall, pp. 76–93.
Smith, R. B., Coupal, J., DeLand, F. H., and Triplett, J. W. (1979). Pharmacokinetics of hepatobiliary imaging agents in rats. J. Nucl. Med. 20:45–49.
Upson, D. W., Gronwall, R. R., and Cornelius, C. E. (1970). Maximal hepatic excretion of bilirubin in sheep. Proc. Soc. Exp. Biol. Med. 134:9–12.
Wagner, J. G. (1976). Scientific commentary: Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of poly exponential equations which have been fitted to the data. J. Pharmacokinet. Biopharm. 4:443–467.
Weinbren, K., and Billing, B. H. (1956). Hepatic clearance of bilirubin as an index of cellular function in the regenerating rat liver. Br. J. Exp. Pathol. 37:199–204.
Whelan, G., and Combes, B. (1975). Phenobarbital enhanced biliary excretion of administered unconjugated and conjugated sulfobromophthalein in the rat. Biochem. Pharmacol. 24:1283–1286.
Wilkinson, G. R., and Shand, D. G. (1975). A physiological approach to hepatic drug clearance, clinical pharmacology and therapeutics. Clin. Pharmacol. Ther. 18:377–390.
Wistow, B. W., Subramanian, G., VanHeertum, R. L., Hendersen, R. W., Gagne, G. M., Hall, R. C., and McAfee, J. G. (1977). An evaluation of 99mTc-labeled hepatobiliary agents. J. Nucl. Med. 18:455–461.
Zimmerman, H. J. Hepatotoxicity:The Adverse Effects of Drugs and Other Chemicals on the Liver. New York: Appleton-Century-Crofts, pp. 180–185, 259–276.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Fritzberg, A.R., Bloedow, D.C. (1983). Animal Models in the Study of Hepatobiliary Radiotracers. In: Lambrecht, R.M., Eckelman, W.C. (eds) Animal Models in Radiotracer Design. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5596-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5596-3_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-5598-7
Online ISBN: 978-1-4612-5596-3
eBook Packages: Springer Book Archive